Meridian Bioscience Receives FDA Clearance For New Campylobacter Test (Medical News Today)
Meridian Bioscience, Inc. (NASDAQ: VIVO) announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) for a new test for Campylobacter. Launched as PREMIER CAMPY, the rapid EIA test provides for optimized detection of Campylobacter infection, the most commonly diagnosed bacteria for food borne illness in the U.S.

FDA Urges Consumers Not To Eat Hundreds Of Products Recalled Because Of Contaminated Peanuts And Peanut Ingredients (Medical News Today)
So far more than 500 cases of foodborne illness caused by Salmonella Typhimurium have been reported. Many of these cases have required hospitalization. The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have confirmed that the sources of this outbreak are peanut products from the Peanut Corporation of America (PCA).